Not an official event of the 2024 ASCO® Annual Meeting. Not sponsored, endorsed, or accredited by ASCO®, Association for Clinical Oncology, or Conquer Cancer® the ASCO Foundation
Saturday, June 1, 2024
6:30 PM – 7:30 PM CT
Please note this live virtual meeting is at: 7:30 PM Eastern; 6:30 PM Central; 5:30 PM Mountain; 4:30 PM Pacific
PROGRAM FEATURES
- Online personalized quality-improvement poster-generation portal
- Downloadable whiteboard animations
FACULTY
 |
Kevin S. Emerick, MD Associate Professor Harvard Medical School Division Director Head and Neck Surgical Oncology and Reconstruction Co-Director NMSC Multidisciplinary Program and Clinic Mass Eye and Ear Boston, MA |
 |
Vishal Patel, MD Director of Cutaneous Oncology, GW Cancer Center Director of Dermatologic Surgery, GW Department of Dermatology Associate Professor of Dermatology & of Medicine/Oncology George Washington University School of Medicine & Health Sciences Washington, DC |
PROGRAM OVERVIEW
The goal of this program is to provide visually engaging education to assist the multidisciplinary care team of cross-specialty clinicians that manage patients with non-melanoma skin cancer. Program faculty will address clinical decisions and strategies to help improve patient-specific care. Program focus includes risk assessment, patient education and clinical communication, along with treatment regimen selections based on clinical guidelines and the latest clinical trial data to optimize long-term outcomes in patients.
TARGET AUDIENCE
This activity is designed to meet the educational needs of dermatologists, dermatopathologists, radiation oncologists, nurse practitioners, Mohs surgeons, medical oncologists, head and neck surgeons, and the multidisciplinary care team who care for patients with either basal cell or cutaneous squamous cell carcinomas.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Articulate the latest clinical evidence for approved and investigational immunotherapeutic approaches for advanced cutaneous squamous cell carcinoma or basal cell carcinoma
- Identify strategies to implement multidisciplinary care for patients with advanced cutaneous squamous cell carcinoma or basal cell carcinoma, including risk assessment, communication, and patient education.
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to the live event at [email protected]
